Effect of Pulsed Magnetic Field Versus Low Level Laser Therapy on Functional Performance in Children With Juvenile Idiopathic Arthritis

January 17, 2024 updated by: Shrouk Abd Elmohsen Taha Basiony Elnhrawy
the purpose of this study is to compare between the effect of pulsed magnetic field versus low level laser therapy on functional performance in children with juvenile idiopathic arthritis

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study directed to investigate effect of pulsed magnetic field versus low level laser therapy on functional performance in children with juvenile idiopathic arthritis children with juvenile idiopathic arthritis suffer from some problems such as pain, swelling and limited motion in knee joints here in this study i used these devices to help in solving these problems pain was measured by visual analogue scale swelling was measured by tape measurement and Range of motion was measured by digital geniometre

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Kafr Elsheikh
      • Kafr Ash Shaykh, Kafr Elsheikh, Egypt
        • Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1 Confirmed diagnosis of Juvenile Idiopathic Arthritis (JIA).
  • 2 Polyarticular onset of JIA with bilateral involvement of the knee joint.
  • 3 Age between 8 and 16 years
  • 4 Stable conditions (i.e., receive stable doses of medications in the past three months).
  • 5 Not participating in a regular exercise program in the past six months.

Exclusion Criteria:

  • 1 Fixed deformities
  • 2 History of joint surgery
  • 3 Ankylosing or fractures
  • 4 Bone destruction ( erosive changes of the knee joints ).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Group (A) received Pulsed magnetic field therapy in addition to traditional exercise program
Device: pulsed magnetic field
Children in this group received pulsed magnetic therapy in addition to traditional exercise program
Experimental: Group B
Group (B) received Low level laser therapy in addition to traditional exercise program
Device: Low level laser
Children in this group received low level laser therapy in addition to traditional exercise program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Swelling
Time Frame: 3 months
We used Tape Measurement to measure Swelling
3 months
Sensation of Pain
Time Frame: 3 months
we used Visual Analogue Scale (VAS) to measure pain. the scale ranged from 0 to 10. ( 0 means no pain and 10 means maximum pain
3 months
Range of motion
Time Frame: 3 months
we used digital geniometer to measure range of motion
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shrouk Abd Elmohsen Taha Basiony Elnhrawy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

August 1, 2023

Study Completion (Actual)

August 1, 2023

Study Registration Dates

First Submitted

January 17, 2024

First Submitted That Met QC Criteria

January 17, 2024

First Posted (Actual)

January 26, 2024

Study Record Updates

Last Update Posted (Actual)

January 26, 2024

Last Update Submitted That Met QC Criteria

January 17, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EG,KFS lab Research 00

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Juvenile Idiopathic Arthritis

Clinical Trials on pulsed magnetic field

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe